Normal Values for the Full Visual Field, Corrected for Age- and Reaction Time, Using Semi-automated Kinetic Testing on the Octopus 900 Perimeter

University Hospital Tuebingen1 site in 1 country86 target enrollmentJune 2006

ConditionsHealthy

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Healthy
Sponsor: University Hospital Tuebingen
Enrollment: 86
Locations: 1
Primary Endpoint: Measurement of the full Visual Field using semi-automated kinetic perimetry.
Status: Completed
Last Updated: 12 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The purpose of this study is to determine normal values of the visual field (VF), corrected for age- and reaction time (RT) using the Octopus 900 perimeter and semi-automated kinetic perimetry (SKP).

Registry

clinicaltrials.gov

Start Date

June 2006

End Date

September 2008

Last Updated

12 years ago

Study Type

Interventional

Study Design

Single Group

Sex

All

Investigators

Sponsor

University Hospital Tuebingen

Responsible Party

Principal Investigator

Ulrich Schiefer

Prof. Dr. med Ulrich Schiefer

University Hospital Tuebingen

Eligibility Criteria

Inclusion Criteria

•maximum spherical ametropia ± 6 Diopters (D)
•maximum cylindrical ametropia ± 2 D
•distant visual acuity ≥ 1.0 logMAR \[20/20\] for subjects up to 60 years, ≥ 0.8 logMAR \[20/25\] for subjects from 61-70 years, ≥ 0.63 logMAR \[20/30\] for subjects older than 70 years
•isocoria, pupil diameter \> 3mm
•intraocular pressure (air pulse tonometer) ≤ 21mmHg
•normal anterior segments
•ocular fundus: normal appearance of the cup to disc ratio (CDR) ≤ 0.5, interocular difference of CDR \< 0.3
•normal macular region, vessels, and peripheral retinal examination (with undilated pupils).

Exclusion Criteria

•amblyopia
•strabismus
•ocular motility disorder
•diseases of the retina
•glaucoma, glaucoma suspect
•macular degeneration
•IOP \> 21 mmHg
•abnormal color vision test (ISPP - Ishihara and Standard Pseudoisochromatic Plates = SPP)
•history or findings of other neuro-ophthalmological disease
•relevant opacities of the central refractive media (cornea, lens, vitreous body)